Atrial Fibrillation

This channel includes news and new technology innovations for the treatment of atrial fibrillation, also referred to as AF or afib. AF is a cardiac arrhythmia caused by irregular and often rapid heart rate. It is caused by the upper chambers (the atria) beating irregularly and uncoordinated with the lower  ventricle chambers of of the heart. Symptoms include weakness with heart palpitations and shortness of breath. The conditional can lead to an increased risk of stroke and heart failure. AF episodes can cause the blood in the atria to stagnate and form clots, usually within the left atrial appendage (LAA). The clots can flow to the brain and cause a stroke. Treatments include anticoagulation therapy to dissolve clots, catheter or surgical ablation and LAA occlusion

Watchman, left atrial appendage closure, LAA occluder
Feature | Left Atrial Appendage (LAA) Occluders | Dave Fornell

Patients with atrial fibrillation (AF or Afib) are high risk for stroke due to the formation of thrombus emboli in the ...

Home August 01, 2016
Home
News | Blood Testing

July 12, 2016 — Following a collaborative process with the U.S. Food and Drug Administration (FDA), Alere Inc. will be ...

Home July 12, 2016
Home
pros and cons of new anticoagulation therapies, anticoagulants, dabigatran, Pradaxa, novel oral anticoagulants, NOACs, rivaroxaban, Xarelto, apixaban, Eliquis
Feature | Antiplatelet and Anticoagulation Therapies | Heidi Olson, Pharm.D

With the recent introduction of several novel oral anticoagulants (NOACs) on the U.S. market that have been billed by ...

Home July 26, 2016
Home
News | EP Mapping and Imaging Systems

July 7, 2016 — Abbott recently announced positive results from three clinical studies investigating the benefits ...

Home July 07, 2016
Home
News | Left Atrial Appendage (LAA) Occluders

July 7, 2016 — AtriCure Inc. announced the first patient has been enrolled in the FROST study at William Beaumont ...

Home July 07, 2016
Home
News | Left Atrial Appendage (LAA) Occluders

July 5, 2016 — AtriCure Inc. announced that it has received CE Mark for the AtriClip PRO2 Left Atrial Appendage (LAA) ...

Home July 05, 2016
Home
News | Cardiovascular Clinical Studies

June 28, 2016 — New research shows patients admitted to National Health Service (NHS) hospitals in the United Kingdom ...

Home June 28, 2016
Home
News | Antiplatelet and Anticoagulation Therapies

June 24, 2016 — More than 1 in 3 atrial fibrillation (AF) patients at intermediate to high risk for stroke are treated ...

Home June 24, 2016
Home
News | Antiplatelet and Anticoagulation Therapies

June 2, 2016 — Female atrial fibrillation patients are less likely than their male counterparts to receive blood ...

Home June 02, 2016
Home
News | Antiplatelet and Anticoagulation Therapies

May 25, 2016 — Technavio’s latest report on the U.S. anticoagulants market provides an analysis on the most important ...

Home May 25, 2016
Home
Watchman, left atrial appendage closure, LAA occluder, LAA. LAAO, laa occluder, left atrial appendage, Watchman
Feature | Left Atrial Appendage (LAA) Occluders | Dave Fornell

Atrial fibrillation (AF) affects nearly 6 million Americans and the condition puts them at significantly greater risk of ...

Home May 20, 2016
Home
News | Atrial Fibrillation

May 19, 2016 — Physician-researchers in the College of Medicine at the University of Cincinnati have developed a ...

Home May 19, 2016
Home
News | Cath Lab

May 19, 2016 — St. Jude Medical Inc. announced results from two cardiovascular clinical trials presented at EuroPCR 2016 ...

Home May 19, 2016
Home
News | Structural Heart

May 16, 2016 — Tricuspid regurgitation (TR) occurs when the heart’s tricuspid valve leaks, allowing blood to flow back ...

Home May 16, 2016
Home
News

May 11, 2016 — Patients with Wolff-Parkinson-White syndrome who receive catheter ablation to cure their abnormal heart ...

Home May 11, 2016
Home
Subscribe Now